TGA warns against advertising mLs and units pricing
12 Aug 2019

The Therapeutic Goods Administration (TGA) has warned doctors against advertising a price per ‘units’ or ‘mLs’ for cosmetic injections.
The warnings came in letters sent to individual doctors following complaints made to the TGA. The letters stated that such pricing “makes an indirect reference to a Schedule 4 (Prescription Only) substance as it is not possible to purchase units of a service”.
The letter further stated:
“Advertisements for cosmetic services MUST NOT specify trade names of products (e.g., Belkyra) containing Schedule 4 substances or ingredients (e.g., deoxycholic acid) that are Schedule 4 substances, or make indirect reference to Schedule 4 substances from which they can be identified as this is a breach of the Act.”
Guidance on legal obligations when advertising therapeutic goods can be found on the TGA’s advertising hub.
Not yet subscribed to receive our medico-legal blog? Scroll down to subscribe and stay connected.
This blog contains general information only. We recommend you contact your medical defence organisation or insurer when you require specific advice in relation to medico-legal matters.
Professional boundaries in healthcare - Part 1
Boundaries with patients present in numerous ways every day and all health practitioners
11 Aug 2025
Understanding Professional Medical Indemnity Insurance
Do you understand the ins and outs of professional medical indemnity insurance?
11 Aug 2025
Professional boundaries in healthcare - Part 2
Boundaries with patients present in numerous ways every day and all health practitioners
11 Aug 2025
Understanding changes to the Fair Work Act
What are the changes to the Fair Work Act and what is my role?
22 Jul 2025